Generic placeholder image

Recent Patents on Cardiovascular Drug Discovery

Editor-in-Chief

ISSN (Print): 2212-3962
ISSN (Online): 1574-8901

Patents in the Diagnosis and Therapy of Neurocardiogenic Syncope

Author(s): Anna Kostopoulou, Efthimios G. Livanis and Vassilis Voudris

Volume 4, Issue 1, 2009

Page: [67 - 71] Pages: 5

DOI: 10.2174/157489009787259973

Price: $65

Abstract

Neurocardiogenic syncope is one of the most common types of syncope, characterized by arterial vasodilatation with or without bradycardia. The regulation of blood pressure and heart rate is the result of a complex reaction between the central and peripheral nervous system with the circulatory system. Multiple therapies, pharmaceutical and interventional, have been applied without any proven effect. The initial positive reports on pacing were not demonstrated in enough number of controlled studies. Neurocardiogenic syncope continues to remain a clinical problem in terms of understanding its underlying mechanisms and therapy needs to be enlightened by future studies. This article provides a background of diagnosis and therapy of neurocardiogenic syncope and reviews some related patents.

Keywords: Syncope, neurocardiogenic, implanted loop recorders, treatment, pacemakers


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy